Synthetic Biologics, Inc. (SYN)
R&D Expense Growth
257.18%
Quarterly · Period ending:
SYN R&D Expense Growth
Latest reported257.18%period ending
Latest reported257.18%period ending
SYN Quarterly R&D Growth (QoQ) (0.00% → 257.18%)
Latest values, visible window
High-resolution chart · PNG
SYN r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 257.1831% | |
| -68.6396% | |
| -55.6252% | |
| 30.6196% | |
| -34.1981% | |
| 54.9869% | |
| 0% | |
| 0% | |
| 27.8647% | |
| 5.2402% | |
| 4.0182% | |
| 11.3619% | |
| -26.2554% | |
| 34.1933% | |
| -6.5491% | |
| 40.9229% | |
| 2.0704% | |
| 72.8086% | |
| 14.1982% | |
| 7.1116% | |
| -42.9819% | |
| -1.9572% | |
| -15.1531% | |
| -53.499% | |
| 59.7533% | |
| 7.2787% | |
| 17.607% | |
| -27.7583% | |
| -20.3247% | |
| 5.9941% | |
| -10.2769% | |
| -9.2096% | |
| -14.3656% | |
| -20.2674% | |
| -9.9569% | |
| -4.7019% | |
| -1.4377% | |
| -12.1521% | |
| -7.9363% | |
| -11.8256% | |
| 33.8039% | |
| 15.6144% | |
| 23.884% | |
| 41.9442% | |
| 30.1727% | |
| 4.4166% | |
| 0.2213% | |
| 83.7966% | |
| 22.6101% | |
| 7.6029% | |
| -89.4439% | |
| 1,288.0734% | |
| 39.4881% | |
| 41.7098% | |
| -84.7976% | |
| 778.6828% | |
| 3.3339% | |
| 20.3699% | |
| 33.8029% | |
| -59.1055% | |
| -24.5174% | |
| 34.1748% | |
| 2,857.0733% | |
| -104.669% | |
| -19.7175% | |
| -18.2157% | |
| 1.781% | |
| -43.5502% | |
| -26.1127% | |
| -45.0084% | |
| -5.9047% | |
| 43.4882% | |
| 45.8329% | |
| -23.8563% | |
| -39.2896% | |
| 0% | |
| 0% | |
| -100% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| -115.4272% | |
| 0% | |
| -100% | |
| -20.6576% | |
| -40.6133% | |
| -67.259% | |
| 40.592% | |
| -13.4773% | |
| -20.9089% | |
| -12.8371% | |
| 84.9696% | |
| -2.2869% | |
| 19.9277% | |
| 1.0938% | |
| -2.1361% | |
| -11.7165% | |
| 13.526% | |
| 12.5% |